Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENIOLISIB vs LERCANIDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENIOLISIB vs LERCANIDIPINE: Safety Overview

Metric LENIOLISIB LERCANIDIPINE
Total FAERS Reports 570 3,767
Deaths Reported 6 248
Death Rate 1.1% 6.6%
Hospitalizations 54 2,249
Average Patient Age 19.4 yrs 65.8 yrs
% Female Patients 27.3% 47.8%
FDA Approval Date Mar 24, 2023 N/A
Manufacturer Pharming Healthcare Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A